The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 2-(2-oxo-3-(2-phenoxyacetamido)-4-styrylazetidin-1-yl)-3-phenylpropanoate ID: ALA2282132
PubChem CID: 71576908
Max Phase: Preclinical
Molecular Formula: C30H30N2O5
Molecular Weight: 498.58
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C(Cc1ccccc1)N1C(=O)C(NC(=O)COc2ccccc2)C1/C=C/c1ccccc1
Standard InChI: InChI=1S/C30H30N2O5/c1-2-36-30(35)26(20-23-14-8-4-9-15-23)32-25(19-18-22-12-6-3-7-13-22)28(29(32)34)31-27(33)21-37-24-16-10-5-11-17-24/h3-19,25-26,28H,2,20-21H2,1H3,(H,31,33)/b19-18+
Standard InChI Key: NMXNARSXNSPCMN-VHEBQXMUSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
10.9702 -23.3012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9700 -24.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2103 -19.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5602 -20.9930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1734 -23.0903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9182 -21.3457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9351 -25.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3379 -26.2463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3395 -21.9285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7077 -27.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9044 -19.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7196 -21.5550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9586 -25.8763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4441 -20.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5448 -26.4584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1390 -20.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3473 -22.9382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1732 -25.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1845 -24.0681 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9545 -21.8800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9099 -27.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3286 -27.2589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2231 -22.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9336 -22.3529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8650 -20.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4778 -19.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5910 -23.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3488 -25.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5910 -24.4972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7666 -23.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9208 -26.8248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5526 -22.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7660 -24.4972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1868 -23.0871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5239 -21.8172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1836 -25.0792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5522 -25.4512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23 35 1 0
5 1 2 0
32 17 2 0
29 18 1 0
37 28 1 0
8 15 1 0
4 25 1 0
12 6 1 0
30 33 1 0
17 24 1 0
2 19 2 0
11 3 1 0
16 25 1 0
29 27 1 0
23 20 2 0
21 10 2 0
27 5 1 0
28 7 1 0
25 11 2 0
27 30 1 0
22 21 1 0
33 36 2 0
18 13 1 0
13 15 1 0
34 23 1 0
2 37 1 0
35 4 1 0
18 2 1 0
3 26 2 0
10 31 1 0
33 29 1 0
6 9 2 0
9 32 1 0
26 14 1 0
30 34 1 0
15 22 2 0
1 32 1 0
24 12 2 0
31 8 2 0
14 16 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 498.58Molecular Weight (Monoisotopic): 498.2155AlogP: 3.65#Rotatable Bonds: 11Polar Surface Area: 84.94Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.09CX Basic pKa: ┄CX LogP: 4.47CX LogD: 4.47Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.32Np Likeness Score: -0.45
References 1. Jarrahpour A, Sheikh J, El-Mounsi I, Mouhoub R, Hadda TB. (2013) Computational evaluation and experimental verification of antibacterial activity of some -lactams: advantages and limitations, 22 (3): [10.1007/s00044-012-0126-7 ]